Zoetis Inc. (ZTS) stock
ZTSNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 16/3045% below fair value
$83.82+0.86 (+1.04%)
Close on Nov 13, 2026Market cap $34.64BP/E 14.1Yield 2.42%
Zoetis EV/EBITDA
EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.
Zoetis's EV/EBITDA was 10.3× on Nov 11, 2026, against 15.3× a year earlier. Over the last 5 years it ranged from 9.0× to 38.7×, with a median of 22.6×.
EV/EBITDA at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 10.3× | −4.7 |
| 2025 | Dec 31, 2025 | 15.1× | −5.7 |
| 2024 | Dec 31, 2024 | 20.7× | −5.8 |
| 2023 | Dec 29, 2023 | 26.5× | +4.2 |
| 2022 | Dec 30, 2022 | 22.3× | −16.4 |
| 2021 | Dec 31, 2021 | 38.7× | +7.9 |
| 2020 | Dec 31, 2020 | 30.8× | +2.7 |
| 2019 | Dec 31, 2019 | 28.1× | +6.8 |
| 2018 | Dec 31, 2018 | 21.3× | −1.1 |
| 2017 | Dec 29, 2017 | 22.4× | +1.7 |
| 2016 | Dec 30, 2016 | 20.7× | −7.4 |
| 2015 | Dec 31, 2015 | 28.1× | +6.1 |
| 2014 | Dec 31, 2014 | 22.1× | +0.8 |
| 2013 | Dec 31, 2013 | 21.2× | – |
See a number that looks wrong?